SkinBioTherapeutics involved in a c.£600k research grant NORTHLAND VIEW SkinBio announced it is the industrial partner for a c.£600k grant awarded by the Biotechnology and Biological Sciences Research Council (BBSRC)

The skin surface is composed of molecules derived from our skin cells, our environment and from the microorganisms living on our skin. The composition and the diversity of skin microorganisms

The microbiome has been generating a lot of buzz lately, and for good reason. Recent studies have shown that there’s a connection between the microbes in your digestive tract and everything from

New patent application filed for SkinBiotix® platform NORTHLAND VIEW SkinBio announced a new patent filing regarding the use of SkinBiotix®, the Company’s proprietary probiotic platform, for increasing filaggrin levels in

SkinBioTherapeutics plc (LON:SBTX), a life science company focused on skin health, announced today a new patent filing. The patent application is to cover the use of SkinBiotix® for increasing filaggrin levels

NIH study suggests a potentially cheap and effective treatment for a painful condition. Inflammation, itching, painful skin lesions: This is everyday life for patients with atopic dermatitis, a type of

Human study design and manufacturing scale-up for cosmetic application NORTHLAND VIEW Human study: SkinBio provided the finalised design of its human study, which aims to test the efficacy of the